Feb 11 (Reuters) - Shares of Australia's CSL Ltd CSL.AX plunged more than 17% in early trading on Wednesday after the biotech giant announced the departure of its chief executive officer, Paul McKenzie, and reported a 7% drop in its first-half earnings.
CSL's shares plunged 17.6% to A$151.350, their lowest since mid-February 2018.
(Reporting by Kumar Tanishk in Bengaluru; Editing by Alan Barona)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.